Literature DB >> 9215664

Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic.

C Moutou1, M C Vincent, V Biancalana, J L Mandel.   

Abstract

In the fragile X syndrome, the transition from unmethylated moderate expansions of the CGG repeat (premutations) to methylated large expansions (full mutations) occurs only through maternal transmission. The risk of such transition is highly correlated with the size of the maternal premutation (PM), being very low for small PM alleles (approximately 60 repeats), to 100% for alleles above 100 repeats. The timing of this transition was the object of much speculation. A postzygotic transition was proposed as a preferred model, based on the observation that males with full mutation (FM) have PM in sperm. Analysis of tissues from affected fetuses, including additional data reported here, indicate that such a putative postzygotic transition would have to occur very early in embryogenesis and most likely before determination of germ cell lineage. At least 15% of carriers of a FM show a significant proportion of white blood cells carrying a PM (mutation mosaics). We performed a simulation study showing that, if transition to FM is postzygotic, one should observe a much higher proportion of such mosaics in offspring of mothers with small PMs. This was compared with the actual pattern observed in 212 mutated offspring of 112 PM carrier mothers. We found no effect of maternal PM size on incidence of mosaicism in leucocytes. We propose that this is strong, albeit indirect evidence against a postzygotic transition to FM. A transition at an early morula stage (before day 3) cannot, however, be formally excluded.

Entities:  

Mesh:

Year:  1997        PMID: 9215664     DOI: 10.1093/hmg/6.7.971

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2015-04       Impact factor: 4.878

Review 2.  Comparative genomics and molecular dynamics of DNA repeats in eukaryotes.

Authors:  Guy-Franck Richard; Alix Kerrest; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

3.  Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

Authors:  D Wöhrle; U Salat; H Hameister; W Vogel; P Steinbach
Journal:  Am J Hum Genet       Date:  2001-07-13       Impact factor: 11.025

4.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

5.  Sperm DNA analysis in a Friedreich ataxia premutation carrier suggests both meiotic and mitotic expansion in the FRDA gene.

Authors:  M B Delatycki; D Paris; R J Gardner; K Forshaw; G A Nicholson; N Nassif; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

6.  Improving preimplantation genetic diagnosis for Fragile X syndrome: two new powerful single-round multiplex indirect and direct tests.

Authors:  Emmanuelle Kieffer; Jean-Christophe Nicod; Nathalie Gardes; Claire Kastner; Nicolas Becker; Catherine Celebi; Olivier Pirrello; Catherine Rongières; Isabelle Koscinski; Philippe Gosset; Céline Moutou
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

7.  Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism.

Authors:  P J White; R H Borts; M C Hirst
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

8.  Huntington disease expansion mutations in humans can occur before meiosis is completed.

Authors:  Song-Ro Yoon; Louis Dubeau; Margot de Young; Nancy S Wexler; Norman Arnheim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

Review 9.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

10.  Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.

Authors:  Beatrice Primerano; Flora Tassone; Randi J Hagerman; Paul Hagerman; Francesco Amaldi; Claudia Bagni
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.